vcure long logo vcure long logo
  • Physiotherapy
  • Health & Fitness
  • News
Reading: £10m UK Program to Accelerate Cardiometabolic Innovation
V CureV Cure
Font ResizerAa
Search
Follow US
© Vcure Healthcare 2025. All Rights Reserved.
London skyline representing the UK's healthcare innovation program.
healthcare news

£10m UK Program to Accelerate Cardiometabolic Innovation

VCure Healthcare
Last updated: November 19, 2026 12:15 PM
By VCure Healthcare
8 Min Read
Share
Photo: wikimedia commons
SHARE

LONDON, UK: The UK has launched a £10 million program to accelerate the development of new treatments, medical devices and digital health technologies for heart disease, diabetes and obesity.

The initiative aims to help promising healthcare innovations reach patients through the NHS, private healthcare providers and international markets.

The program will bring together research institutions, healthcare companies, private hospitals and NHS organizations. It will support early-stage ventures, clinical testing and the adoption of proven technologies to improve cardiometabolic health.

How the New UK Program Will Transform Cardiometabolic Healthcare

The Frontier Innovation for Cardiometabolic Disease Program is backed by £10 million from UK Research and Innovation’s (UKRI) Local Innovation Partnerships Fund, with support from the Mayor of London.

The UK-first initiative is designed to address a major gap in healthcare innovation. Many promising treatments and technologies struggle to reach patients because companies cannot easily generate the clinical evidence needed for wider adoption.

The program has two complementary parts, each receiving £5 million: Venture Builder and Validate and Scale.

The announcement was reported by News-Medical on November 17, 2026, based on information provided by UCLPartners.

Why London Needs More Cardiometabolic Health Innovations

Cardiovascular disease remains a major public health challenge in London. It causes approximately one in four deaths in the capital, accounting for around 13,000 deaths every year.

Around 70% of cardiovascular disease is considered preventable. However, more than 500,000 Londoners have high blood pressure without knowing it. This increases their risk of heart attacks and strokes.

The burden is also greater in deprived communities and populations experiencing health inequalities. Earlier diagnosis, effective treatment and improved access to preventive care could help reduce avoidable complications.

The initiative will support the objectives of the London Million Hearts and Minds CVD Prevention Program, which brings together the NHS, local government, communities and industry to improve cardiovascular health. Its priorities include earlier detection of high blood pressure, high cholesterol and irregular heart rhythms. (NHS England, 2026)

Labelled diagram of the human heart and its main chambers.
Photo: wikimedia commons

1. Venture Builder: Supporting New Treatments and Medical Technologies

The £5 million Venture Builder program will help researchers and entrepreneurs turn promising scientific discoveries into healthcare businesses.

It will focus on two areas:

  • Therapeutics development: Bio Innovation Institute (BII), an innovation organization supported by the Novo Nordisk Foundation, will help develop new therapeutic solutions for cardiometabolic diseases.
  • Medical technology development: King’s College London’s London Institute for Healthcare Engineering (LIHE) will support medical devices and digital health innovations.

King’s Health Partners will also contribute to the wider initiative.

The partnership combines BII’s experience in building life science ventures with King’s expertise in healthcare engineering, clinical evaluation and medical technology development. It aims to help innovators address funding, regulatory and commercialization challenges.

The program expects to support more than 30 ventures, initiate four to six clinical trials and attract approximately £200 million in private investment. (King’s College London, 2026)

Medical laboratory scientists working on healthcare research.
Photo: magnific

2. Validate and Scale: Testing Innovations in Real Healthcare Settings

The second £5 million program will help companies test their technologies in real clinical environments before wider adoption.

UCLPartners is leading this initiative in collaboration with:

  • Harley Street Health District
  • Imperial College Health Partners
  • Health Innovation Network South London

The Harley Street Health District will provide access to independent hospitals, clinics and clinical expertise. According to Mark Kildea, Chief Executive of Harley Street Health District, approximately 40% of London’s independent healthcare activity takes place in this district.

Many specialists working in Harley Street also practice within the NHS. This creates opportunities for healthcare companies to test technologies with real patients and generate evidence that can support wider clinical adoption.

The program aims to engage more than 100 companies, provide tailored support to at least 20 and help at least five high-growth companies validate and scale their products.

It also aims to attract between £50 million and £100 million in private investment. (UCLPartners, 2026)

Which Healthcare Innovations Will Receive Priority?

The program will cover the full cardiometabolic prevention pathway, from identifying health risks early to improving long-term disease management.

Its priorities include:

  • Early risk identification: Technologies that detect people at risk of cardiovascular and metabolic conditions.
  • Disease prevention: Innovations that reduce risk and support healthier lifestyle choices.
  • Blood pressure management: Solutions for identifying and managing hypertension.
  • Heart rhythm monitoring: Technologies that help detect and manage atrial fibrillation.
  • Cholesterol management: Innovations that support better identification and ongoing management of high cholesterol.

The program will also priorities technologies that address health inequalities. Testing across London’s diverse communities will help establish whether innovations can meet the needs of different patient groups. (UCLPartners, 2026)

ECG machine used for cardiac monitoring and heart rhythm assessment.
Photo: nara

Expected Investment and Economic Impact

Beyond improving healthcare, the program aims to strengthen London’s life sciences industry and create new employment opportunities.

Its combined targets include:

Program targetExpected outcome
Total UKRI funding£10 million
Venture Builder investment target£200 million
Validate and Scale investment target£50 million to £100 million
Combined private investment ambitionUp to £300 million
New high-value jobsUp to 1,000
Ventures supportedMore than 30
Clinical trials4 to 6
Companies engaged through Validate and ScaleMore than 100
Companies receiving tailored supportAt least 20

These figures represent program ambitions rather than guaranteed outcomes. The initiative also aims to help successful healthcare technologies enter NHS services, grow within private healthcare and expand into international markets. (UCLPartners, 2026)

What This Means for the Future of Cardiometabolic Healthcare

The £10 million initiative introduces a collaborative approach to healthcare innovation by connecting research, business development and clinical practice.

Private healthcare providers can offer companies opportunities to test technologies and gather clinical evidence. The NHS can then help proven solutions reach a larger patient population through its healthcare services.

The involvement of London’s three health innovation networks will further support the spread of effective technologies across NHS services.

The program’s long-term impact will depend on how successfully it turns promising research into clinically effective solutions.

However, its focus on early development, real-world validation and wider adoption could help address important gaps in heart disease, diabetes and obesity prevention and management.

More Read

NHS vaccination station helping London residents access seasonal vaccinations.
London NHS Starts Winter Vaccination Drive

You Might Also Like

Taking Lansoprazole for Reflux? Avoid This Common Mistake

Targeted Physiotherapy Trial Aims to Reduce Migraines and Neck Pain

Indian Government Screens 146 Mln Women for Breast Cancer

A Revolutionary Weight-Loss And Diabetes Drug Launched In India

Metformin and Painkillers: What Patients Need to Know

TAGGED:London NHS
Share This Article
Facebook Email Copy Link Print

Latest

Fresh passion fruit showing its edible pulp and seeds
Alpha-Amyrin and Alzheimer’s: What New Research Found
healthcare news
People with Down syndrome participating in a cooking activity.
Tofacitinib Shows Promise in Down Syndrome Trial
healthcare news
Frequent nosebleeds in children
Frequent nosebleeds in children? Know The Warning Signs!
Child & Mother Care Physiotherapy
Constipation in children
Constipation in Children: How to Recognise the Signs Early
Child & Mother Care Physiotherapy

More Articles

Fresh passion fruit showing its edible pulp and seeds
healthcare news

Alpha-Amyrin and Alzheimer’s: What New Research Found

By VCure Healthcare
9 Min Read
People with Down syndrome participating in a cooking activity.

Tofacitinib Shows Promise in Down Syndrome Trial

By VCure Healthcare
London skyline representing the UK's healthcare innovation program.
healthcare news

£10m UK Program to Accelerate Cardiometabolic Innovation

By VCure Healthcare
8 Min Read
Child & Mother CarePhysiotherapy

Frequent nosebleeds in children? Know The Warning Signs!

A sudden nosebleed can be frightening for both children and parents. It may happen during play,…

By Dr. Kruti Raj (PT, MUHS, CPT, CMPT)
Child & Mother CarePhysiotherapy

Constipation in Children: How to Recognise the Signs Early

Childhood constipation is common, but it is not always a problem that can be resolved by…

By Dr. Kruti Raj (PT, MUHS, CPT, CMPT)
Child & Mother CarePhysiotherapy

Enlarged Tonsils in Children: 10 Signs Parents Should Never Ignore

Enlarged tonsils are common during childhood. In many children, they do not cause any noticeable problems.…

By Dr. Kruti Raj (PT, MUHS, CPT, CMPT)
Child & Mother CarePhysiotherapy

Recurrent Ear Infections in Children? Watch for These Signs

Ear infections are common during childhood, particularly in babies and preschool-aged children. Most children recover without…

By Dr. Kruti Raj (PT, MUHS, CPT, CMPT)
Child & Mother CarePhysiotherapy

Wheezing in Children: Warning Signs You Should Never Ignore

Wheezing in children can be frightening for parents, particularly when it starts suddenly or occurs during…

By Dr. Kruti Raj (PT, MUHS, CPT, CMPT)
Child & Mother CarePhysiotherapy

Persistent Cough in Children: Common Causes and Warning Signs

A cough that continues for several weeks can be worrying for parents, especially when it disturbs…

By Dr. Kruti Raj (PT, MUHS, CPT, CMPT)
V Cure

Vcure Healthcare is All-in-One integrated Healthcare platform which helps to better manage chronic illnesses, prescription management & creates a continuum of care.

Categories

  • Physiotherapy
  • Health & Fitness
  • Child & Mother Care
  • Mental Health
  • Lifestyle
  • Diet & Nutrition
  • womens health
  • healthcare news

Quick Links

  • About Us
  • Contact

© Vcure Healthcare 2025. All Rights Reserved.

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up